A
American International Group, Inc.
AIG · Financial Services
Q4 FY2025
Earning ended Dec 31, 2025Report generated Mar 7, 2026
AIG's Transformation Is Real, But the Tail Still Bites
Most investors are still discounting AIG through the 2008 bailout lens, missing that 17 consecutive quarters below 90% combined ratio represents underwriting discipline that most specialty peers never sustain for even half that stretch — the market is pricing a conglomerate that no longer exists while the actual specialty P&C engine compounds quietly underneath.
Flowly Score
Apr 16 Close
+79%$78.22
Fair Value
$140.00
62
Averageat $78.22
Business Strengthmoderate
The specialty P&C franchise emerging from the restructuring has real moat characteristics — a century of proprietary loss data in political risk, environmental casualty, and aerospace that no new entrant can shortcut — but ROIC remains thin, and AI-driven underwriting commoditization threatens the expertise premium in exactly the lines AIG depends on. This is a cleaner, more coherent business than it was five years ago, not a fundamentally stronger one.
Financial Resiliencemoderate
Post-Corebridge, the cash engine is genuine — FCF tracks earnings and the asset-light P&C model requires minimal reinvestment, producing real free cash. The Altman Z-Score of 0.68 is technically distress territory, though insurance balance sheet structures routinely produce misleading Z-Scores; the Piotroski of 6/9 and improving OCF quality are the more honest signal here.
Growth & Trajectorymoderate
The revenue decline is optical noise from the Corebridge removal, not operational deterioration — and management's low-to-mid-teens net premiums written guidance for 2026, backed by 17 consecutive quarters below a 90% combined ratio, is the most credible evidence the transformation has traction. The Everest portfolio conversion and Convex partnership are real premium growth levers, not accounting maneuvers.
Valuationstrong
A mid-teens earnings multiple with a nearly 7% FCF yield and aggressive buyback compounding is genuinely attractive for a specialty insurer posting its best underwriting results in a generation — the market is still discounting AIG at bailout-era skepticism when the actual operating business has materially de-risked. The DCF figures should be ignored as methodologically inappropriate for insurance, but the multiples-based case is straightforward and compelling.
Riskmoderate
The tail that could truly hurt this stock is not a bad catastrophe quarter but silent reserve deterioration in long-tail casualty lines written during softer market years — the kind of loss that surfaces three to five years after premiums are booked and appears suddenly rather than gradually. Add correlated cyber loss exposure and CEO transition uncertainty, and there is enough uncertainty to keep the risk rating squarely in the middle.
The investment case rests on a real mismatch between what the market thinks AIG is and what it has actually become. The Corebridge separation was not a rebranding exercise — it was a genuine strategic amputation that left behind a focused specialty insurer competing in cyber, D&O, political risk, and complex commercial liability with a century of proprietary claims data and pricing infrastructure that no entrant can replicate quickly. At the current multiple, you are paying a mid-tier price for what is increasingly a high-tier underwriting operation, with buybacks running at a rate that compounds per-share value even in a flat operating environment. The earnings yield is competitive against investment-grade credit alternatives, and the Corebridge monetization provides a known capital return catalyst as the remaining stake is liquidated. The trajectory from here has a few visible engines. The Everest portfolio conversion is already showing retention well above expectations, which is a real-world stress test of AIG's ability to compete on underwriting quality rather than just price. The Convex partnership expands premium volume through a capital-light structure, and GenAI initiatives in claims triage and submission evaluation are tracking ahead of management projections — not immaterial when expense ratio compression toward a sub-30% target is part of the core investment thesis for 2027. The CEO transition is the near-term wildcard: Zaffino built the current culture, and his move to executive chair introduces execution risk that is real but not disqualifying given the depth of institutional change already embedded. The single most dangerous risk has nothing to do with catastrophes or cyber attacks — it is reserve development in long-tail casualty lines. AIG wrote substantial general liability, D&O, and umbrella business during softer market years when pricing was aggressive industry-wide, and the full cost of those vintage years will not appear in the income statement for years. Social inflation — the structural trend toward larger jury verdicts and broader court interpretations of policy language — is systematically increasing tail severity across exactly these categories. If reserve additions begin surfacing at meaningful scale, the FCF profile that makes current valuations look compelling could compress sharply and without much warning, turning a patient value thesis into an extended wait with capital impaired along the way.